Last updated at 05 Jul 2024 07:37 AM
Director
DIN: 07727293
Asmita Ameya Sahasrabudhe is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at ALOKA DIAGNOSTICS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07727293.Asmita Ameya Sahasrabudhe has previously been associated with 1 company in roles such as Additional Director.Asmita Ameya Sahasrabudhe is currently involved in 2 different roles. Their most recent position is with ICON HOSPITAL PRIVATE LIMITED as a Director. The first company Asmita Ameya Sahasrabudhe was appointed to as a director was ALOKA DIAGNOSTICS LLP. Asmita Ameya Sahasrabudhe is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Asmita Ameya Sahasrabudhe is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at ALOKA DIAGNOSTICS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07727293.Asmita Ameya Sahasrabudhe has previously been associated with 1 company in roles such as Additional Director.Asmita Ameya Sahasrabudhe is currently involved in 2 different roles. Their most recent position is with ICON HOSPITAL PRIVATE LIMITED as a Director. The first company Asmita Ameya Sahasrabudhe was appointed to as a director was ALOKA DIAGNOSTICS LLP. Asmita Ameya Sahasrabudhe is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 9m 11 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ICON HOSPITAL PRIVATE LIMITED | Director | 29-Sep-2017 |